{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:24:30Z","timestamp":1788362670728,"version":"build-2803163510"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.1001\/jamapediatrics.2018.4296","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T11:12:15Z","timestamp":1547032335000},"page":"211","source":"Crossref","is-referenced-by-count":13,"title":["Carelessness About Surfactant Dose\u2014A Cultural Problem, a Legal Issue, or an Open Research Question?"],"prefix":"10.1001","volume":"173","author":[{"given":"Silvia","family":"Foligno","sequence":"first","affiliation":[{"name":"Division of Pediatrics, Transportation, and Neonatal Critical Care, H\u00f4pital Antoine B\u00e9cl\u00e8re, South Paris University Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"De Luca","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, Transportation, and Neonatal Critical Care, H\u00f4pital Antoine B\u00e9cl\u00e8re, South Paris University Hospitals, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"},{"name":"Physiopathology and Therapeutic Innovation Unit, South Paris\u2013Saclay University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"pvp180040r1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000448985","article-title":"European consensus guidelines on the management of respiratory distress syndrome\u20142016 update.","volume":"111","author":"Sweet","year":"2017","journal-title":"Neonatology"},{"issue":"12","key":"pvp180040r2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1203\/00006450-198612000-00011","article-title":"Surfactant quantity and composition during recovery from hyaline membrane disease.","volume":"20","author":"Jackson","year":"1986","journal-title":"Pediatr Res"},{"issue":"2","key":"pvp180040r3","doi-asserted-by":"publisher","first-page":"F182","DOI":"10.1136\/archdischild-2015-310195","article-title":"Appropriateness of surfactant dosing for preterm babies with respiratory distress syndrome: retrospective cohort study.","volume":"101","author":"Jourdain","year":"2016","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"pvp180040r4","article-title":"Underdosing of surfactant for preterm babies with respiratory distress syndrome in clinical practice: a retrospective cohort study","author":"Boix","year":"2018","journal-title":"Am J Perinatol"},{"issue":"8","key":"pvp180040r5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamapediatrics.2015.0504","article-title":"Nonintubated surfactant application vs conventional therapy in extremely preterm infants: a randomized clinical trial.","volume":"169","author":"Kribs","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"1","key":"pvp180040r6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.siny.2004.09.004","article-title":"Medical liability, risk management, and the quality of health care.","volume":"10","author":"Donn","year":"2005","journal-title":"Semin Fetal Neonatal Med"},{"issue":"3","key":"pvp180040r7","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00134-010-2091-2","article-title":"Pharmacokinetics and clinical predictors of surfactant redosing in respiratory distress syndrome.","volume":"37","author":"Cogo","year":"2011","journal-title":"Intensive Care Med"},{"issue":"9","key":"pvp180040r8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2165\/00148581-200305090-00006","article-title":"The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome: a postmarketing phase IV study.","volume":"5","author":"Lamboley-Gilmert","year":"2003","journal-title":"Paediatr Drugs"},{"issue":"3 spec No.","key":"pvp180040r9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1136\/adc.69.3_Spec_No.276","article-title":"Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial).","volume":"69","author":"Halliday","year":"1993","journal-title":"Arch Dis Child"},{"issue":"3","key":"pvp180040r10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.pupt.2009.01.001","article-title":"Exogenous porcine surfactants increase the infiltration of leukocytes in the lung of rats.","volume":"22","author":"Sun","year":"2009","journal-title":"Pulm Pharmacol Ther"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamapediatrics\/article-pdf\/173\/3\/211\/17301978\/jamapediatrics_foligno_2019_vp_180040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T16:09:00Z","timestamp":1551715740000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpedi.jamanetwork.com\/article.aspx?doi=10.1001\/jamapediatrics.2018.4296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2018.4296","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,1]]}}}